SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-042847
Filing Date
2018-08-08
Accepted
2018-08-08 16:31:55
Documents
52
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv499345_10q.htm 10-Q 288467
2 EXHIBIT 31.1 tv499345_ex31-1.htm EX-31.1 10811
3 EXHIBIT 31.2 tv499345_ex31-2.htm EX-31.2 10808
4 EXHIBIT 32.1 tv499345_ex32-1.htm EX-32.1 4420
5 EXHIBIT 32.2 tv499345_ex32-2.htm EX-32.2 4303
  Complete submission text file 0001144204-18-042847.txt   4063366

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sbot-20180630.xml EX-101.INS 1191370
7 XBRL TAXONOMY EXTENSION SCHEMA sbot-20180630.xsd EX-101.SCH 30960
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sbot-20180630_cal.xml EX-101.CAL 30692
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sbot-20180630_def.xml EX-101.DEF 198730
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sbot-20180630_lab.xml EX-101.LAB 244253
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sbot-20180630_pre.xml EX-101.PRE 224473
Mailing Address 332 EAST SCOTT STREET PORT HUENEME CA 93041
Business Address 332 EAST SCOTT STREET PORT HUENEME CA 93041 (805) 488-2800
Stellar Biotechnologies, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1029
Type: 10-Q | Act: 34 | File No.: 001-37619 | Film No.: 181001843
SIC: 2834 Pharmaceutical Preparations